Júlio Oliveira

Dr. Júlio Oliveira is the board president of IPO Porto, Portugal’s leading comprehensive cancer center, where he has served as Medical Oncologist since 2011. He completed his medical degree at the University of Porto and specialized in Clinical Pharmacology in 2017. Dr. Oliveira founded and leads IPO Porto’s Early Phase Clinical Trials Unit, the first Phase 1 oncology unit in Portugal, and coordinates both the Precision Oncology Program and Molecular Tumor Board. As a principal investigator, he has directed several phase I-III clinical trials and innovative translational research projects. Dr. Oliveira continues to drive groundbreaking research in immuno-oncology and genomics, advancing personalized cancer care and translational oncology at IPO Porto. In 2014 was elected to the board of OECI (Organization of European Cancer Institutes) as Executive Secretary.

Updated: September 2025